Drugs / PQ Grass
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT04687059 | Oct 2020 → Aug 2021 | seasonal allergic rhinitis | Allergy Therapeutics | Completed | Met primary |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT05540717 | Oct 2022 → Nov 2023 | seasonal allergic rhinitis | Allergy Therapeutics | Completed | Met primary |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2018-05-21 | Allergy Therapeutics | Results Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration allergytherapeutics.com ↗
As part of a programme designed to get PQ Grass formally approved in both Europe and the US, AGY has announced positive results from its Phase II dose-ranging clinical trial. |
| 2017-09-18 | Allergy Therapeutics | Regulatory Approval for PQ Grass Phase II trial allergytherapeutics.com ↗
Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, today announces that the fully-funded Phase II clinical trial investigating the dosing of PQ Grass has received clinical trial application (CTA) approval. |
All press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2018-05-21 | Allergy Therapeutics | Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration allergytherapeutics.com ↗ |
| 2018-02-12 | Allergy Therapeutics | Completion of recruitment in PQ Grass Ph II trial allergytherapeutics.com ↗ |
| 2017-10-19 | Allergy Therapeutics | Commencement of dosing in PQ Grass Phase II Trial allergytherapeutics.com ↗ |
| 2017-09-18 | Allergy Therapeutics | Approval for PQ Grass Phase II trial allergytherapeutics.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PQ Grass | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05540717 ↗ |
| Route | Subcutaneous | “A short-course pre-seasonal subcutaneous injection of PQ Grass” PMID 40626378 ↗ Jul 2025 |